• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

S-腺苷-L-甲硫氨酸的帕金森病样效应:左旋多巴的作用

Parkinson's disease-like effects of S-adenosyl-L-methionine: effects of L-dopa.

作者信息

Charlton C G, Crowell B

机构信息

Department of Physiology, Meharry Medical College, Nashville, TN 37208.

出版信息

Pharmacol Biochem Behav. 1992 Oct;43(2):423-31. doi: 10.1016/0091-3057(92)90172-c.

DOI:10.1016/0091-3057(92)90172-c
PMID:1359575
Abstract

The major symptoms of Parkinson's disease (PD) are due to degeneration of the nigrostriatal pathway and depletion of dopamine (DA). Tyrosine hydroxylase (TH), norepinephrine (NE), serotonin (5-HT), and melanin pigments are also decreased and acetylcholinergic activity increased. Biochemically, increased methylation can cause the depletion of DA, NE, 5-HT, and melanin pigments and also an increase of acetylcholine; thus, increased methylation can present a biochemical picture that resembles the biochemical changes that occur in PD. During the therapy of PD with L-dopa, it is well known that L-dopa reacts avidly with S-adenosyl-L-methionine (SAM), the biologic methyl donor, to produce 3-O-methyl-dopa. Correspondingly, L-dopa has been shown to deplete the concentration of SAM, and SAM has been found to induce PD-like motor impairments in rodents; therefore, an excess of SAM-dependent methylation may be associated with Parkinsonism. To further study the effects of methylation, SAM was injected into the lateral ventricle of rats. SAM caused tremors, rigidity, abnormal posture, and dose-related hypokinesia. Doses of 9.38, 50, and 400 nM/rat caused 61.9, 73.4, and 94.8% reduction, respectively, of motor activity. A 200-mg/kg IP dose of L-dopa, given before 50 nM SAM, blocked the SAM-induced hypokinesia. SAM also caused a decrease in TH immunoreactivity, apparent degeneration of TH-containing fibers, loss of neurons, and the accumulation of phagocytic cells in the substantia nigra. These results showed that excess SAM in the brain, probably due to its ability to increase methylation, can induce symptoms that resemble some of the changes that occur in PD.

摘要

帕金森病(PD)的主要症状是由于黑质纹状体通路变性和多巴胺(DA)耗竭所致。酪氨酸羟化酶(TH)、去甲肾上腺素(NE)、5-羟色胺(5-HT)和黑色素也减少,而乙酰胆碱能活性增加。从生化角度来看,甲基化增加可导致DA、NE、5-HT和黑色素耗竭,同时乙酰胆碱增加;因此,甲基化增加可呈现出与PD中发生的生化变化相似的生化图景。在用左旋多巴治疗PD期间,众所周知,左旋多巴与生物甲基供体S-腺苷-L-甲硫氨酸(SAM)发生剧烈反应,生成3-O-甲基多巴。相应地,已证明左旋多巴会消耗SAM的浓度,并且发现SAM会在啮齿动物中诱发类似PD的运动障碍;因此,过量的SAM依赖性甲基化可能与帕金森症有关。为了进一步研究甲基化的影响,将SAM注入大鼠侧脑室。SAM引起震颤、僵硬、异常姿势以及与剂量相关的运动迟缓。剂量为9.38、50和400 nM/大鼠时,分别导致运动活性降低61.9%、73.4%和94.8%。在给予50 nM SAM之前给予200 mg/kg腹腔注射剂量的左旋多巴,可阻断SAM诱导的运动迟缓。SAM还导致TH免疫反应性降低、含TH纤维明显变性、神经元丢失以及黑质中吞噬细胞积聚。这些结果表明,大脑中过量的SAM可能由于其增加甲基化的能力,可诱发类似于PD中出现的一些变化的症状。

相似文献

1
Parkinson's disease-like effects of S-adenosyl-L-methionine: effects of L-dopa.S-腺苷-L-甲硫氨酸的帕金森病样效应:左旋多巴的作用
Pharmacol Biochem Behav. 1992 Oct;43(2):423-31. doi: 10.1016/0091-3057(92)90172-c.
2
Substantia nigra degeneration and tyrosine hydroxylase depletion caused by excess S-adenosylmethionine in the rat brain. Support for an excess methylation hypothesis for parkinsonism.大鼠脑中过量S-腺苷甲硫氨酸导致黑质变性和酪氨酸羟化酶耗竭。对帕金森病甲基化过量假说的支持。
Mol Neurobiol. 1994 Aug-Dec;9(1-3):149-61. doi: 10.1007/BF02816115.
3
Striatal dopamine depletion, tremors, and hypokinesia following the intracranial injection of S-adenosylmethionine: a possible role of hypermethylation in parkinsonism.颅内注射S-腺苷甲硫氨酸后纹状体多巴胺耗竭、震颤和运动减退:高甲基化在帕金森病中的可能作用。
Mol Chem Neuropathol. 1995 Dec;26(3):269-84. doi: 10.1007/BF02815143.
4
Depletion of nigrostriatal and forebrain tyrosine hydroxylase by S-adenosylmethionine: a model that may explain the occurrence of depression in Parkinson's disease.S-腺苷甲硫氨酸导致黑质纹状体和前脑酪氨酸羟化酶耗竭:一种可能解释帕金森病中抑郁症发生的模型。
Life Sci. 1997;61(5):495-502. doi: 10.1016/s0024-3205(97)00409-8.
5
S-adenosyl-L-methionine decreases motor activity in the rat: similarity to Parkinson's disease-like symptoms.S-腺苷-L-甲硫氨酸降低大鼠的运动活性:与帕金森病样症状相似。
Behav Neural Biol. 1993 May;59(3):186-93. doi: 10.1016/0163-1047(93)90950-m.
6
Farnesyl-L-cysteine analogs block SAM-induced Parkinson's disease-like symptoms in rats.
Pharmacol Biochem Behav. 2000 Aug;66(4):841-9. doi: 10.1016/s0091-3057(00)00274-4.
7
Effects of L-dopa treatment on methylation in mouse brain: implications for the side effects of L-dopa.左旋多巴治疗对小鼠脑内甲基化的影响:与左旋多巴副作用的关联
Life Sci. 2000;66(23):2277-88. doi: 10.1016/s0024-3205(00)00557-9.
8
Noradrenaline neuron degeneration contributes to motor impairments and development of L-DOPA-induced dyskinesia in a rat model of Parkinson's disease.去甲肾上腺素能神经元变性导致帕金森病大鼠模型的运动障碍和左旋多巴诱导的运动障碍的发展。
Exp Neurol. 2014 Jul;257:25-38. doi: 10.1016/j.expneurol.2014.04.011. Epub 2014 Apr 18.
9
L-dopa upregulates the expression and activities of methionine adenosyl transferase and catechol-O-methyltransferase.左旋多巴上调甲硫氨酸腺苷转移酶和儿茶酚-O-甲基转移酶的表达及活性。
Exp Neurol. 2001 Sep;171(1):127-38. doi: 10.1006/exnr.2001.7726.
10
The effects of L-dopa on the activity of methionine adenosyltransferase: relevance to L-dopa therapy and tolerance.左旋多巴对甲硫氨酸腺苷转移酶活性的影响:与左旋多巴治疗及耐受性的相关性。
Neurochem Res. 1993 Mar;18(3):325-30. doi: 10.1007/BF00969090.

引用本文的文献

1
A prebiotic dietary pilot intervention restores faecal metabolites and may be neuroprotective in Parkinson's Disease.一项益生元饮食试点干预可恢复粪便代谢物,且可能对帕金森病具有神经保护作用。
NPJ Parkinsons Dis. 2025 Apr 4;11(1):66. doi: 10.1038/s41531-025-00885-5.
2
"Dopamine homeostasis" requires balanced polypharmacy: Issue with destructive, powerful dopamine agents to combat America's drug epidemic.“多巴胺稳态”需要平衡的联合用药:使用具有破坏性的强效多巴胺药物来对抗美国的毒品泛滥问题。
J Syst Integr Neurosci. 2017 Nov;3(6). doi: 10.15761/JSIN.1000183. Epub 2017 Nov 17.
3
Parkinson's disease managing reversible neurodegeneration.
帕金森病:应对可逆性神经退行性变
Neuropsychiatr Dis Treat. 2016 Apr 5;12:763-75. doi: 10.2147/NDT.S98367. eCollection 2016.
4
5-HTP efficacy and contraindications.5-HTP 的功效和禁忌症。
Neuropsychiatr Dis Treat. 2012;8:323-8. doi: 10.2147/NDT.S33259. Epub 2012 Jul 19.
5
Amino acid management of Parkinson's disease: a case study.帕金森病的氨基酸管理:案例研究。
Int J Gen Med. 2011 Feb 28;4:165-74. doi: 10.2147/IJGM.S16621.